Compare HPQ & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HPQ | DGX |
|---|---|---|
| Founded | 1939 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.8B | 21.0B |
| IPO Year | 2002 | 1996 |
| Metric | HPQ | DGX |
|---|---|---|
| Price | $25.58 | $200.29 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $21.42 | ★ $214.38 |
| AVG Volume (30 Days) | ★ 21.6M | 623.9K |
| Earning Date | 05-27-2026 | 04-21-2026 |
| Dividend Yield | ★ 5.96% | 1.82% |
| EPS Growth | N/A | ★ 13.78 |
| EPS | 1.07 | ★ 2.24 |
| Revenue | ★ $55,295,000,000.00 | $11,035,000,000.00 |
| Revenue This Year | $3.10 | $7.53 |
| Revenue Next Year | $0.39 | $3.77 |
| P/E Ratio | ★ $24.53 | $87.54 |
| Revenue Growth | 3.24 | ★ 11.78 |
| 52 Week Low | $17.56 | $164.65 |
| 52 Week High | $29.65 | $213.50 |
| Indicator | HPQ | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 57.84 | 63.13 |
| Support Level | $18.30 | $194.09 |
| Resistance Level | $26.04 | $212.16 |
| Average True Range (ATR) | 1.46 | 3.82 |
| MACD | 0.17 | 0.83 |
| Stochastic Oscillator | 54.67 | 90.02 |
HP (formerly Hewlett-Packard) is a behemoth in the PC and printing markets. It has focused on these markets since it exited IT infrastructure in 2015 with the split from Hewlett Packard Enterprise. HP focuses on the commercial market, but maintains sales of consumer devices and printers. The firm has a broad and global customer base, with only one third of sales coming from the US. HP completely outsources manufacturing and relies heavily on channel partners for its sales and marketing.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.